• Consensus Rating: N/A
  • Consensus Price Target: €0.00
  • Forecasted Upside: -100.00%
  • Number of Analysts: 0
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
€91.28
▼ -0.22 (-0.24%)

This chart shows the closing price for SAN by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Sanofi Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for SAN and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for SAN

Analyst Price Target is €0.00
▼ -100.00% Downside Potential
This price target is based on 0 analysts offering 12 month price targets for Sanofi in the last 3 months. The average price target is €0.00, with a high forecast of €0.00 and a low forecast of €10,000,000.00. The average price target represents a -100.00% upside from the last price of €91.28.

This chart shows the closing price for SAN for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is N/A

The current consensus among 0 investment analysts is to n/a stock in Sanofi. This N/A consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
7/1/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
9/29/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/28/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
3/27/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/25/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
9/23/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
11/22/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/22/2024

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
1/28/2022Deutsche Bank AktiengesellschaftSet Target€80.00
1/27/2022The Goldman Sachs GroupSet Target€124.00
1/26/2022JPMorgan Chase & Co.Set Target€105.00
1/13/2022JPMorgan Chase & Co.Set Target€105.00
1/6/2022UBS GroupSet Target€117.00
1/5/2022Credit Suisse GroupSet Target€96.00
1/4/2022Sanford C. BernsteinSet Target€120.00
1/4/2022JPMorgan Chase & Co.Set Target€105.00
12/15/2021Jefferies Financial GroupSet Target€120.00
12/10/2021JPMorgan Chase & Co.Set Target€105.00
12/7/2021Jefferies Financial GroupSet Target€120.00
12/6/2021UBS GroupSet Target€116.00
12/3/2021Deutsche Bank AktiengesellschaftSet Target€80.00
12/2/2021BarclaysSet Target€90.00
12/2/2021Credit Suisse GroupSet Target€96.00
12/2/2021Kepler Capital MarketsSet Target€105.00
12/1/2021JPMorgan Chase & Co.Set Target€105.00
11/30/2021UBS GroupSet Target€116.00
11/24/2021UBS GroupSet Target€100.00
11/11/2021The Goldman Sachs GroupSet Target€124.00
11/1/2021Deutsche Bank AktiengesellschaftSet Target€80.00
10/29/2021Credit Suisse GroupSet Target€96.00
10/29/2021UBS GroupSet Target€100.00
10/29/2021JPMorgan Chase & Co.Set Target€105.00
10/28/2021Morgan StanleySet Target€106.00
10/28/2021The Goldman Sachs GroupSet Target€113.00
10/28/2021Jefferies Financial GroupSet Target€120.00
10/28/2021JPMorgan Chase & Co.UpgradeNeutral
10/28/2021Kepler Capital MarketsSet Target€105.00
10/28/2021Sanford C. BernsteinSet Target€120.00
10/26/2021Deutsche Bank AktiengesellschaftSet Target€80.00
10/21/2021UBS GroupSet Target€100.00
10/14/2021The Goldman Sachs GroupSet Target€113.00
10/11/2021JPMorgan Chase & Co.Set Target€100.00
10/7/2021Jefferies Financial GroupSet Target€120.00
10/5/2021Deutsche Bank AktiengesellschaftSet Target€80.00
10/4/2021JPMorgan Chase & Co.Set Target€100.00
9/29/2021UBS GroupSet Target€100.00
9/28/2021JPMorgan Chase & Co.Set Target€100.00
9/23/2021Deutsche Bank AktiengesellschaftSet Target€80.00
9/9/2021UBS GroupSet Target€100.00
9/8/2021BarclaysSet Target€90.00
9/8/2021Jefferies Financial GroupSet Target€120.00
9/2/2021Jefferies Financial GroupSet Target€120.00
9/1/2021Deutsche Bank AktiengesellschaftSet Target€80.00
8/10/2021The Goldman Sachs GroupSet Target€113.00
8/4/2021UBS GroupSet Target€101.00
8/4/2021JPMorgan Chase & Co.Set Target€100.00
8/4/2021The Goldman Sachs GroupSet Target€109.00
7/30/2021Credit Suisse GroupSet Target€96.00
7/29/2021The Goldman Sachs GroupSet Target€109.00
7/29/2021JPMorgan Chase & Co.Set Target€93.00
7/20/2021JPMorgan Chase & Co.Set Target€93.00
7/12/2021Jefferies Financial GroupSet Target€120.00
7/7/2021The Goldman Sachs GroupSet Target€109.00
7/1/2021JPMorgan Chase & Co.Set Target€93.00
6/15/2021Berenberg BankSet TargetNeutral€92.00
6/14/2021The Goldman Sachs GroupSet TargetBuy€105.00
6/8/2021Credit Suisse GroupSet TargetBuy€96.00
6/7/2021The Goldman Sachs GroupSet TargetBuy€105.00
6/4/2021Jefferies Financial GroupSet TargetBuy€110.00
6/2/2021Baader BankReiterated RatingBuy
6/1/2021The Goldman Sachs GroupSet TargetBuy€105.00
5/25/2021JPMorgan Chase & Co.Set TargetBuy€93.00
5/24/2021UBS GroupSet TargetBuy€101.00
5/19/2021Credit Suisse GroupSet TargetBuy€96.00
5/19/2021JPMorgan Chase & Co.Set TargetBuy€93.00
5/17/2021UBS GroupSet TargetBuy€101.00
5/11/2021Deutsche Bank AktiengesellschaftSet TargetSell€75.00
5/5/2021JPMorgan Chase & Co.Set TargetBuy€93.00
5/4/2021The Goldman Sachs GroupSet TargetBuy€105.00
4/30/2021Deutsche Bank AktiengesellschaftSet TargetSell€75.00
4/29/2021Credit Suisse GroupSet TargetBuy€96.00
4/29/2021BarclaysSet TargetNeutral€90.00
4/28/2021The Goldman Sachs GroupSet TargetBuy€101.00
4/26/2021JPMorgan Chase & Co.Set TargetBuy€93.00
4/26/2021UBS GroupSet TargetBuy€101.00
4/15/2021UBS GroupSet TargetBuy€101.00
4/14/2021JPMorgan Chase & Co.Set TargetBuy€93.00
4/12/2021The Goldman Sachs GroupSet TargetBuy€101.00
4/8/2021JPMorgan Chase & Co.Set TargetBuy€93.00
4/7/2021Deutsche Bank AktiengesellschaftSet TargetSell€70.00
4/6/2021BarclaysSet TargetNeutral€85.00
4/6/2021Credit Suisse GroupSet TargetBuy€96.00
4/1/2021Deutsche Bank AktiengesellschaftSet TargetSell€70.00
3/31/2021Credit Suisse GroupSet TargetBuy€96.00
3/15/2021The Goldman Sachs GroupSet TargetBuy€106.00
3/15/2021JPMorgan Chase & Co.Set TargetBuy€93.00
3/2/2021Deutsche Bank AktiengesellschaftSet TargetSell€70.00
2/16/2021Deutsche Bank AktiengesellschaftSet TargetSell€70.00
2/15/2021The Goldman Sachs GroupSet TargetBuy€106.00
2/15/2021JPMorgan Chase & Co.Set TargetBuy€93.00
2/10/2021UBS GroupSet TargetBuy€101.00
2/8/2021Credit Suisse GroupSet TargetBuy€96.00
2/8/2021Deutsche Bank AktiengesellschaftSet TargetSell€70.00
2/8/2021Jefferies Financial GroupSet TargetBuy€110.00
2/8/2021The Goldman Sachs GroupSet TargetBuy€103.00
2/8/2021JPMorgan Chase & Co.Set TargetBuy€93.00
9/29/2020Jefferies Financial GroupSet TargetBuy€110.00
9/29/2020JPMorgan Chase & Co.Set TargetBuy€106.00
9/29/2020Berenberg BankSet TargetNeutral€92.00
8/18/2020UBS GroupSet TargetBuy€100.00
8/18/2020Credit Suisse GroupSet TargetBuy€105.00
8/17/2020JPMorgan Chase & Co.Set TargetBuy€106.00
8/17/2020The Goldman Sachs GroupSet TargetBuy€103.00
7/31/2020JPMorgan Chase & Co.Set TargetBuy€106.00
7/30/2020BarclaysSet TargetNeutral€85.00
7/30/2020Credit Suisse GroupSet TargetBuy€105.00
7/29/2020The Goldman Sachs GroupSet TargetBuy€105.00
7/29/2020Kepler Capital MarketsSet TargetBuy€99.00
7/29/2020Sanford C. BernsteinSet TargetBuy€108.00
7/29/2020Jefferies Financial GroupSet TargetBuy€110.00
7/16/2020The Goldman Sachs GroupSet TargetBuy€105.00
7/9/2020JPMorgan Chase & Co.Set TargetBuy€103.00
6/25/2020JPMorgan Chase & Co.Set TargetBuy€103.00
6/25/2020UBS GroupSet TargetBuy€101.00
6/24/2020The Goldman Sachs GroupSet TargetBuy€105.00
6/22/2020Oddo BhfSet TargetBuy€106.00
6/19/2020UBS GroupSet TargetBuy€101.00
6/18/2020JPMorgan Chase & Co.Set TargetBuy€103.00
6/17/2020The Goldman Sachs GroupSet TargetBuy€105.00
6/12/2020Credit Suisse GroupSet TargetBuy€105.00
6/10/2020The Goldman Sachs GroupSet TargetBuy€106.00
6/9/2020Morgan StanleySet TargetBuy€107.00
6/3/2020Credit Suisse GroupSet TargetBuy€105.00
6/1/2020JPMorgan Chase & Co.Set TargetBuy€103.00
5/26/2020JPMorgan Chase & Co.Set TargetBuy€103.00
5/26/2020UBS GroupSet TargetBuy€101.00
5/12/2020The Goldman Sachs GroupSet TargetBuy€106.00
5/7/2020UBS GroupSet TargetBuy€103.00
5/6/2020The Goldman Sachs GroupSet TargetBuy€106.00
4/27/2020Credit Suisse GroupSet TargetBuy€105.00
4/27/2020The Goldman Sachs GroupSet TargetBuy€105.00
4/24/2020UBS GroupSet TargetBuy€103.00
4/23/2020JPMorgan Chase & Co.Set TargetBuy€103.00
4/21/2020The Goldman Sachs GroupSet TargetBuy€105.00
4/15/2020Sanford C. BernsteinSet TargetBuy€105.00
4/14/2020Deutsche Bank AktiengesellschaftSet TargetBuy€99.00
4/9/2020JPMorgan Chase & Co.Set TargetBuy€103.00
4/7/2020The Goldman Sachs GroupSet TargetBuy€104.00
3/31/2020Oddo BhfSet TargetBuy€91.00
3/19/2020The Goldman Sachs GroupSet TargetBuy€104.00
3/18/2020Sanford C. BernsteinSet TargetBuy€108.00
3/17/2020BarclaysSet TargetNeutral€80.00
3/11/2020The Goldman Sachs GroupSet TargetBuy€104.00
3/5/2020The Goldman Sachs GroupSet TargetNeutral€104.00
2/27/2020UBS GroupSet TargetBuy€104.00
2/25/2020JPMorgan Chase & Co.Set TargetBuy€103.00
2/21/2020UBS GroupSet TargetBuy€104.00
2/12/2020Deutsche Bank AktiengesellschaftSet TargetBuy€99.00
2/12/2020HSBCSet TargetNeutral€89.00
2/12/2020BarclaysSet TargetSell€85.00
2/12/2020JPMorgan Chase & Co.Set TargetBuy€103.00
2/10/2020Kepler Capital MarketsSet TargetBuy€99.00
2/7/2020Credit Suisse GroupSet TargetBuy€105.00
2/7/2020Sanford C. BernsteinSet TargetBuy€100.00
2/6/2020UBS GroupSet TargetBuy€89.50
2/6/2020BarclaysSet TargetSell€80.00
2/6/2020The Goldman Sachs GroupSet TargetNeutral€100.00
2/6/2020JPMorgan Chase & Co.Set TargetBuy€103.00
2/6/2020Jefferies Financial GroupSet TargetBuy€110.00
2/4/2020Morgan StanleySet TargetBuy€105.00
1/27/2020JPMorgan Chase & Co.Set TargetBuy€103.00
1/24/2020The Goldman Sachs GroupSet TargetNeutral€100.00
1/16/2020BarclaysSet TargetSell€80.00
1/16/2020Credit Suisse GroupSet TargetBuy€105.00
1/6/2020JPMorgan Chase & Co.Set TargetBuy€103.00
1/6/2020Morgan StanleySet TargetBuy€105.00
1/6/2020Sanford C. BernsteinSet TargetBuy€100.00
1/1/2020BarclaysSet TargetSell€80.00
1/1/2020Kepler Capital MarketsSet TargetBuy€96.00
12/26/2019BarclaysSet TargetSell€80.00
12/26/2019Kepler Capital MarketsSet TargetBuy€96.00
(Data available from 12/22/2019 forward)

News Sentiment Rating

0.17 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 5 very positive mentions
  • 20 positive mentions
  • 2 negative mentions
  • 2 very negative mentions
5/26/2024
  • 1 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
6/25/2024
  • 0 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
7/25/2024
  • 4 very positive mentions
  • 14 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
8/24/2024
  • 1 very positive mentions
  • 19 positive mentions
  • 4 negative mentions
  • 1 very negative mentions
9/23/2024
  • 1 very positive mentions
  • 37 positive mentions
  • 5 negative mentions
  • 2 very negative mentions
10/23/2024
  • 5 very positive mentions
  • 12 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
11/22/2024
  • 5 very positive mentions
  • 15 positive mentions
  • 3 negative mentions
  • 1 very negative mentions
12/22/2024

Current Sentiment

  • 5 very positive mentions
  • 15 positive mentions
  • 3 negative mentions
  • 1 very negative mentions

Recent Stories by Sentiment

Sanofi logo
Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, Canada, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products. In addition, it offers poliomyelitis, pertussis, and hib pediatric vaccines; influenza, booster, meningitis, and travel and endemic vaccines, which includes hepatitis A, typhoid, cholera, yellow fever, and rabies vaccines. The company also provides cough, cold, and flu, allergy, and pain care products, as well as physical, mental, and digestive wellness products; and offers products for itching, hydration, aging, cracking, overnight, and specialty skincare needs like eczema. Further, it has a collaboration and license agreement with Exscientia to develop up to 15 novel small-molecule for oncology and immunology; ABL Bio, Inc. to develop ABL301, a treatment for alpha-synucleinopathies; Blackstone Life Sciences to develop pivotal studies and clinical development program; and Seagen Inc. to design, develop, and commercialize antibody-drug conjugates for cancer. Additionally, the company has a collaboration agreement with IGM Biosciences, Inc. to develop, manufacture, and commercialize IgM antibody; Skyhawk Therapeutics, Inc to discover and develop novel small molecules; and Adagene Inc., for the discovery and development of antibody-based therapies. It also has collaborations with Scribe Therapeutics Inc. to develop genome editing technologies; and co-promotion service agreement with Provention Bio, Inc. for the commercialization of teplizumab. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was incorporated in 1994 and is headquartered in Paris, France.
Read More

Today's Range

Now: €91.28
Low: €89.93
High: €91.62

50 Day Range

MA: €94.88
Low: €88.82
High: €101.58

52 Week Range

Now: €91.28
Low: €63.09
High: €92.97

Volume

4,412,378 shs

Average Volume

3,050,000 shs

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of Sanofi?

The following Wall Street analysts have issued stock ratings on Sanofi in the last twelve months:
View the latest analyst ratings for SAN.

What is the current price target for Sanofi?

0 Wall Street analysts have set twelve-month price targets for Sanofi in the last year. has the lowest price target set, forecasting a price of €10,000,000.00 for Sanofi in the next year.
View the latest price targets for SAN.

What is the current consensus analyst rating for Sanofi?

Sanofi currently has from Wall Street analysts. The stock has a consensus analyst rating of "N/A."
View the latest ratings for SAN.

How do I contact Sanofi's investor relations team?

Sanofi's physical mailing address is 54 rue la Boetie, PARIS, 75008, France. The company's listed phone number is +33-1-53774000. The official website for Sanofi is en.sanofi.com. Learn More about contacing Sanofi investor relations.